David McClung
Director of Finance/CFO at BIOCARDIA INC
Net worth: 55 240 $ as of 2024-03-30
Profile
David McClung is a Member of The American Institute of Certified Public Accountants and the California Society of Certified Public Accountants.
He is also the Chief Financial Officer at BioCardia, Inc. since 2017.
Previously, he worked as the Finance Director & Controller at Sonitus Medical, Inc. from 2011 to 2013.
He also served as the Director-Internal Audit at Matson Navigation Co., Inc. and as the Controller at NextWave Pharmaceuticals, Inc. from 2010 to 2011.
Additionally, he held the position of Controller at BioCardia, Inc. from 2013 to 2016.
Mr. McClung completed his undergraduate degree at Georgia State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOCARDIA, INC.
0.52% | 2023-08-24 | 135,724 ( 0.52% ) | 55 240 $ | 2024-03-30 |
David McClung active positions
| Companies | Position | Start |
|---|---|---|
| BIOCARDIA INC | Director of Finance/CFO | 2016-02-29 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - |
| California Society of Certified Public Accountants | Corporate Officer/Principal | - |
Former positions of David McClung
| Companies | Position | End |
|---|---|---|
Sonitus Medical, Inc.
 Sonitus Medical, Inc. Medical DistributorsDistribution Services Sonitus Medical, Inc. designs and develops hearing aids. Its SoundBite hearing system is non-surgical and removable hearing solution that imperceptibly transmits sound via the teeth. The firm offer this devices to hearing professionals such as otologists, ENTs, and audiologists. The company was founded in June 2006 by Amir Abolfathi and is headquartered in San Mateo, CA. | Director of Finance/CFO | 2013-07-31 |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 2011-05-31 |
Matson Navigation Co., Inc.
 Matson Navigation Co., Inc. Marine ShippingTransportation Matson Navigation Co., Inc. provides freight transportation services. The company was founded in 1882 and is headquartered in Honolulu, HI. | Comptroller/Controller/Auditor | - |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Director of Finance/CFO | - |
Training of David McClung
| Georgia State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOCARDIA INC | Health Technology |
| Private companies | 6 |
|---|---|
Sonitus Medical, Inc.
Sonitus Medical, Inc. Medical DistributorsDistribution Services Sonitus Medical, Inc. designs and develops hearing aids. Its SoundBite hearing system is non-surgical and removable hearing solution that imperceptibly transmits sound via the teeth. The firm offer this devices to hearing professionals such as otologists, ENTs, and audiologists. The company was founded in June 2006 by Amir Abolfathi and is headquartered in San Mateo, CA. | Distribution Services |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
Matson Navigation Co., Inc.
Matson Navigation Co., Inc. Marine ShippingTransportation Matson Navigation Co., Inc. provides freight transportation services. The company was founded in 1882 and is headquartered in Honolulu, HI. | Transportation |
| California Society of Certified Public Accountants | |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |
- Stock Market
- Insiders
- David McClung
